Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality

Trends in Immunology

Volumn 29, Issue 4, 2008, Pages 195-201

  Thorley Lawson, David A ^a   Duca, Karen A ^b   Shapiro, Michael ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

BIOLOGICAL MODEL; CELL TYPE; COMPUTER MODEL; DRUG EFFICACY; DRUG SENSITIVITY; EPSTEIN BARR VIRUS; HERPES VIRUS; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; MEMORY CELL; MOLECULAR MECHANICS; NONHUMAN; PERSISTENT INFECTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRTUAL REALITY; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS REPLICATION;

B-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; COMPUTER GRAPHICS; COMPUTER SIMULATION; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MODELS, BIOLOGICAL; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 41149092838     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.01.006     Document Type: Review

References (49)

1. Roizman B., and Pellett P.E. The Family Herpesviridae: a brief introduction. In: Fields B.N., and Knipe D.M. (Eds). Virology Vol. 2 (2001), Raven Press 2381-2397
2. Kieff E., and Rickinson A.B. Epstein-Barr virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Virology Vol.2 (2001), Lippincott Williams and Wilkins 2511-2574
3. Rickinson A.B., and Kieff E. Epstein-Barr virus. In: Knipe D.M., and Howley P.M. (Eds). Virology Vol. 2 (2001), Lippincott Williams and Wilkins 2575-2628
4. Thorley-Lawson D.A. Epstein-Barr virus. In: Austen K.F., et al. (Ed). Sampter's Immunologic Diseases Vol .2 (2001), Williams and Wilkins 970-985
5. Thorley-Lawson D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1 (2001) 75-82
6. Thorley-Lawson D.A. EBV the prototypical human tumor virus-just how bad is it?. J. Allergy Clin. Immunol. 116 (2005) 251-261
7. Thorley-Lawson D.A., and Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350 (2004) 1328-1337
8. Roizman B., and Knipe D.M. Herpes simplex viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Virology Vol.2 (2001), Lippincott Williams and Wilkins 2399-2459
9. Vossen M.T., et al. Viral immune evasion: a masterpiece of evolution. Immunogenetics 54 (2002) 527-542
10. Chang Y., and Moore P.S. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. Infect. Agents Dis. 5 (1996) 215-222
11. Hoagland R.J. The transmission of infectious mononucleosis. Am. J. Med. Sci. 229 (1955) 262-272
12. Babcock G.J., et al. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13 (2000) 497-506
13. Joseph A.M., et al. EBV persistence involves strict selection of latently infected B cells. J. Immunol. 165 (2000) 2975-2981
14. Caldwell R.G., et al. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9 (1998) 405-411
15. Casola S., et al. B cell receptor signal strength determines B cell fate. Nat. Immunol. 5 (2004) 317-327
16. Gires O., et al. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16 (1997) 6131-6140
17. He B., et al. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J. Immunol. 171 (2003) 5215-5224
18. Panagopoulos D., et al. Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo. J. Virol. 78 (2004) 13253-13261
19. Hochberg D., et al. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 239-244
20. Cui C., et al. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 80 (2006) 5499-5508
21. Pfeffer S., et al. Identification of microRNAs of the herpesvirus family. Nat. Methods 2 (2005) 269-276
22. Gupta A., et al. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442 (2006) 82-85
23. Anagnostopoulos I., et al. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85 (1995) 744-750
24. Laichalk L.L., and Thorley-Lawson D.A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79 (2005) 1296-1307
25. Niedobitek G., et al. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J. Pathol. 182 (1997) 151-159
26. Laichalk L.L., et al. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16 (2002) 745-754
27. Borza C.M., and Hutt-Fletcher L.M. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 8 (2002) 594-599
28. Hudnall S.D., et al. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod. Pathol. 18 (2005) 519-527
29. Pegtel D.M., et al. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J. Virol. 78 (2004) 12613-12624
30. Walling D.M., et al. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. J. Infect. Dis. 184 (2001) 1499-1507
31. Duca K.A., et al. A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog 3 (2007) 1388-1400
32. Shapiro, M. et al. A virtual look at Epstein-Barr Virus infection: simulation mechanism. J. Theor. Biol. (in press)
33. Davenport M.P., et al. Clonal selection, clonal senescence, and clonal succession: The evolution of the T cell response to infection with a persistent virus. J. Immunol. 168 (2002) 3309-3317
34. Castiglione F., et al. Simulating Epstein-Barr virus infection with C-ImmSim. Bioinformatics 23 (2007) 1371-1377
35. Hoagland R. The incubation period of infectious mononucleosis. Am. J. Public Health Nations Health 54 (1964) 1699-1704
36. Torre D., and Tambini R. Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand. J. Infect. Dis. 31 (1999) 543-547
37. Yao Q.Y., et al. Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int. J. Cancer 43 (1989) 67-71
38. Mentzer S.J., et al. Epstein-Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate. Transpl. Infect. Dis. 3 (2001) 177-185
39. Doherty P.C., et al. Dissecting the host response to a gamma-herpesvirus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (2001) 581-593
40. Flano E., et al. A mouse model for infectious mononucleosis. Immunol. Res. 25 (2002) 201-217
41. Stevenson P.G., and Efstathiou S. Immune mechanisms in murine gammaherpesvirus-68 infection. Viral Immunol. 18 (2005) 445-456
42. Virgin H.W. Immune regulation of viral infection and vice versa. Immunol. Res. 32 (2005) 293-315
43. Speck S.H., and Virgin H.W. Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis. Curr. Opin. Microbiol. 2 (1999) 403-409
44. Willer D.O., and Speck S.H. Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J. Virol. 77 (2003) 8310-8321
45. Tibbetts S.A., et al. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J. Virol. 77 (2003) 7696-7701
46. Wang F. A new animal model for Epstein-Barr virus pathogenesis. Curr. Topics Microbiol. Immunol. 258 (2001) 201-219
47. Nowak M.A., and May R.M. Virus Dynamics: Mathematical Principles of Immunology and Virology (2000), Oxford University Press
48. Perelson A.S. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2 (2002) 28-36
49. Wodarz D. Killer Cell Dynamics: Mathematical and Computational Approaches to Immunology (2007), Springer